IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
This study is currently recruiting participants.
Verified July 2017 by Walid Shaib, MD, Hoosier Cancer Research Network
Sponsor:
Walid Shaib, MD
Collaborators:
Eli Lilly and Company
Hoosier Cancer Research Network
Information provided by (Responsible Party):
Walid Shaib, MD, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT02581215
First received: October 19, 2015
Last updated: July 10, 2017
Last verified: July 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2019 |
| Estimated Primary Completion Date: | March 2018 (Final data collection date for primary outcome measure) |